That’s the view of Robeco investor Jeroen Blokland, who says there are still many positives for stocks, despite the outbreak of the deadly virus in China that is now spreading across the world.
“The unexpected and unfortunate coronavirus outbreak is putting pressure on the sustainability of the improvement in global growth momentum,” says Blokland, senior portfolio manager with Robeco’s Multi Asset team, which has reduced its exposure to equities as a precaution.
“The fact that the uptick in momentum had only just started makes it relatively vulnerable to any negative shocks. In addition, the significant amount of uncertainty related to containing the virus as well as its economic impact require an appropriately cautious stance on risky assets.”
“‘Appropriate’, however, does not imply getting too gloomy too early, as other factors remain positive for risky assets, and for equities in particular.”
The coronavirus, which began in Wuhan, has now spread across and outside China. The government has reacted by putting Wuhan into lockdown, severely restricting movement in other Chinese cities and extending the Chinese New Year holiday to stop people traveling.
“The measures, which might seem drastic, are likely to increase the odds of containment,” says Blokland. “At the same time, however, they are also likely to impact Chinese growth, and therefore also global growth.”
“From this angle, comparisons to the outbreak of the SARS virus back 2003 are futile. The Chinese share of global GDP has more than tripled since then, and China has become the marginal buyer of virtually every commodity. Its sheer size means other emerging countries in the region will face at least a temporary setback in growth as well.”
“It is the combination of a growth shock in China – by far the most important country in terms of share of global GDP – and the uncertainty of how long and how deep this shock will be that has made us erase our overweight to equities in our Multi Asset fund. However, this does not mean we have become outrightly negative on equities.”
Blokland says there are three reasons to be cheerful about equities. “First, when compared to ‘similar’ events, economic activity that is lost during a viral outbreak is largely recouped once it is contained,” he says. “For example, during the SARS outbreak, Chinese retail sales growth briefly halved before making a strong comeback after the virus was brought under control, making up for most of the sales decline.”
“Other parts of the economy such as construction were hit as well, but they also recovered once the spreading of the virus started to decline. We expect to see a similar pattern this time, and do not forecast a major interruption of global supply chains.”
“Second, the global economy showed numerous signs of improvement prior to the outbreak. One example is the global manufacturing PMI, which rose to 50.4 in January, its highest level since April 2019. The ISM Manufacturing Index is also back above 50, following a much bigger-than-expected rise in January.”
“The Citi Global Economic Surprise Index has turned positive and risen to its highest level in almost two years. Export growth in very open economies such as South Korea has improved markedly, revealing that the downward pressure from the China-US trade war is abating.”
“And roughly halfway through the US company reporting season for the fourth quarter of 2019, earnings surprises are the strongest they have been in the last three quarters, with sales surprises the most upbeat in the last four quarters.”
“Earnings revisions have improved significantly on the outlook of better global growth. And in emerging markets, they are now higher than in the US, suggesting earnings momentum is broadening.”
Finally, investors should bear highly accommodative central bank policy in mind, Blokland says. “Short-term interest rates remain low or even negative, with central bank balance sheets growing again,” he says. “In addition, central banks have made it very clear that the hurdle to monetary policy tightening is very high.”
“Both the US Federal Reserve and the European Central Bank are ‘rethinking’ their monetary policy, with a very likely outcome that they will allow inflation to overshoot the target to make up for lost inflation in the past. At the same time, their willingness to increase stimulus is high if a negative shock like the coronavirus were to endanger the global economy.”
“The Chinese central bank already injected a massive amount of liquidity once markets reopened after the Chinese New Year. Global liquidity remains enormous, and will grow even larger in the coming quarters.”
In all, it’s too early to be too gloomy about equities, he says. “Proportionate cautiousness concerning the coronavirus is warranted; obviously the fact that it originated in China – by far the largest growth engine in the world – is of importance here,” he says.
“We would like to stress, however, that other more constructive forces for equities are also at play. Given the fact that events such as the coronavirus tend to have a temporary rather than a structural impact on growth and earnings, we refrain from becoming outrightly negative on equity markets.”
The Robeco Capital Growth Funds have not been registered under the United States Investment Company Act of 1940, as amended, nor or the United States Securities Act of 1933, as amended. None of the shares may be offered or sold, directly or indirectly in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act of 1933, as amended (the “Securities Act”)). Furthermore, Robeco Institutional Asset Management B.V. (Robeco) does not provide investment advisory services, or hold itself out as providing investment advisory services, in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act).
This website is intended for use only by non-U.S. Persons outside of the United States (within the meaning of Regulation S promulgated under the Securities Act who are professional investors, or professional fiduciaries representing such non-U.S. Person investors. By clicking “I Agree” on our website disclaimer and accessing the information on this website, including any subdomain thereof, you are certifying and agreeing to the following: (i) you have read, understood and agree to this disclaimer, (ii) you have informed yourself of any applicable legal restrictions and represent that by accessing the information contained on this website, you are not in violation of, and will not be causing Robeco or any of its affiliated entities or issuers to violate, any applicable laws and, as a result, you are legally authorized to access such information on behalf of yourself and any underlying investment advisory client, (iii) you understand and acknowledge that certain information presented herein relates to securities that have not been registered under the Securities Act, and may be offered or sold only outside the United States and only to, or for the account or benefit of, non-U.S. Persons (within the meaning of Regulation S under the Securities Act), (iv) you are, or are a discretionary investment adviser representing, a non-U.S. Person (within the meaning of Regulation S under the Securities Act) located outside of the United States and (v) you are, or are a discretionary investment adviser representing, a professional non-retail investor. Access to this website has been limited so that it shall not constitute directed selling efforts (as defined in Regulation S under the Securities Act) in the United States and so that it shall not be deemed to constitute Robeco holding itself out generally to the public in the U.S. as an investment adviser. Nothing contained herein constitutes an offer to sell securities or solicitation of an offer to purchase any securities in any jurisdiction. We reserve the right to deny access to any visitor, including, but not limited to, those visitors with IP addresses residing in the United States.
This website has been carefully prepared by Robeco. The information contained in this publication is based upon sources of information believed to be reliable. Robeco is not answerable for the accuracy or completeness of the facts, opinions, expectations and results referred to therein. Whilst every care has been taken in the preparation of this website, we do not accept any responsibility for damage of any kind resulting from incorrect or incomplete information. This website is subject to change without notice. The value of the investments may fluctuate. Past performance is no guarantee of future results. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency. For investment professional use only. Not for use by the general public.